KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationsCost Of SalesEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOpex As A % Of RevenueProperty, Plant & Equipment, Net BreakdownR&D As A %R&D SegregationRevenueRevenue By Customer TypeRevenue By Customer Type %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue By SegmentRevenue By Segment %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Revenue: 2009-2024

Historic Revenue for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $957.8 million.

  • Acadia Pharmaceuticals' Revenue rose 11.27% to $278.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 12.69%. This contributed to the annual value of $957.8 million for FY2024, which is 31.85% up from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Revenue stood at $957.8 million for FY2024, which was up 31.85% from $726.4 million recorded in FY2023.
  • Acadia Pharmaceuticals' Revenue's 5-year high stood at $957.8 million during FY2024, with a 5-year trough of $441.8 million in FY2020.
  • For the 3-year period, Acadia Pharmaceuticals' Revenue averaged around $733.8 million, with its median value being $726.4 million (2023).
  • Data for Acadia Pharmaceuticals' Revenue shows a peak YoY spiked of 40.45% (in 2023) over the last 5 years.
  • Over the past 5 years, Acadia Pharmaceuticals' Revenue (Yearly) stood at $441.8 million in 2020, then climbed by 9.60% to $484.1 million in 2021, then increased by 6.83% to $517.2 million in 2022, then spiked by 40.45% to $726.4 million in 2023, then spiked by 31.85% to $957.8 million in 2024.